Cargando…
Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Theref...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676075/ https://www.ncbi.nlm.nih.gov/pubmed/37997884 http://dx.doi.org/10.1177/17534666231199670 |
_version_ | 1785149902596079616 |
---|---|
author | Kahnert, Kathrin Lempert, Lilli Maria Behr, Jürgen Elsner, Laura Bolt, Toki Tufman, Amanda Kauffmann-Guerrero, Diego |
author_facet | Kahnert, Kathrin Lempert, Lilli Maria Behr, Jürgen Elsner, Laura Bolt, Toki Tufman, Amanda Kauffmann-Guerrero, Diego |
author_sort | Kahnert, Kathrin |
collection | PubMed |
description | BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Therefore, we sought to examine whether we could find prognostic markers in pre-therapeutic lung function testing of SCLC patients. PATIENTS AND METHODS: We retrospectively analysed a cohort of 205 patients with the diagnosis of SCLC between 2010 and 2018. Pre-therapeutic values of spirometry, body plethysmography and measurement of diffusing capacity was extracted from patients’ charts. Comparisons between groups were performed using the Mann–Whitney U-test or by chi-square tests as appropriate. Kaplan–Meier analyses and COX-regression models were performed to correlate lung function parameters with patients’ outcome. RESULTS: Airway obstruction itself, or the diagnosis chronic obstructive pulmonary disease (COPD) based on GOLD definitions did not correlate with survival in SCLC patients. Hyperinflation measured by increased residual volume and residual volume to total lung capacity ratio (log-rank p < 0.001) and reduced diffusing capacity (log-rank p = 0.007) were associated with reduced survival. Furthermore, patients with hyperinflation as well as impairments in gas exchange representing an emphysematic phenotype had the worst outcome (log-rank p < 0.001). CONCLUSION: We recommend including body plethysmography and measurement of diffusing capacity in the pre-therapeutic assessment of SCLC patients. Our findings suggest that reduction of hyperinflation may lead to better outcome in SCLC patients. Thus, in addition to effective tumour therapy, adequate therapy of the comorbidity of COPD should also be provided. In particular, measures to reduce hyperinflation by means of dual bronchodilation as well as respiratory physiotherapy should be further assessed in this setting. |
format | Online Article Text |
id | pubmed-10676075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-106760752023-11-24 Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing Kahnert, Kathrin Lempert, Lilli Maria Behr, Jürgen Elsner, Laura Bolt, Toki Tufman, Amanda Kauffmann-Guerrero, Diego Ther Adv Respir Dis Original Research BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Therefore, we sought to examine whether we could find prognostic markers in pre-therapeutic lung function testing of SCLC patients. PATIENTS AND METHODS: We retrospectively analysed a cohort of 205 patients with the diagnosis of SCLC between 2010 and 2018. Pre-therapeutic values of spirometry, body plethysmography and measurement of diffusing capacity was extracted from patients’ charts. Comparisons between groups were performed using the Mann–Whitney U-test or by chi-square tests as appropriate. Kaplan–Meier analyses and COX-regression models were performed to correlate lung function parameters with patients’ outcome. RESULTS: Airway obstruction itself, or the diagnosis chronic obstructive pulmonary disease (COPD) based on GOLD definitions did not correlate with survival in SCLC patients. Hyperinflation measured by increased residual volume and residual volume to total lung capacity ratio (log-rank p < 0.001) and reduced diffusing capacity (log-rank p = 0.007) were associated with reduced survival. Furthermore, patients with hyperinflation as well as impairments in gas exchange representing an emphysematic phenotype had the worst outcome (log-rank p < 0.001). CONCLUSION: We recommend including body plethysmography and measurement of diffusing capacity in the pre-therapeutic assessment of SCLC patients. Our findings suggest that reduction of hyperinflation may lead to better outcome in SCLC patients. Thus, in addition to effective tumour therapy, adequate therapy of the comorbidity of COPD should also be provided. In particular, measures to reduce hyperinflation by means of dual bronchodilation as well as respiratory physiotherapy should be further assessed in this setting. SAGE Publications 2023-11-24 /pmc/articles/PMC10676075/ /pubmed/37997884 http://dx.doi.org/10.1177/17534666231199670 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Kahnert, Kathrin Lempert, Lilli Maria Behr, Jürgen Elsner, Laura Bolt, Toki Tufman, Amanda Kauffmann-Guerrero, Diego Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title | Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title_full | Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title_fullStr | Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title_full_unstemmed | Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title_short | Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing |
title_sort | hyperinflation and reduced diffusing capacity predict prognosis in sclc: value of extended pre-therapeutic lung function testing |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676075/ https://www.ncbi.nlm.nih.gov/pubmed/37997884 http://dx.doi.org/10.1177/17534666231199670 |
work_keys_str_mv | AT kahnertkathrin hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT lempertlillimaria hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT behrjurgen hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT elsnerlaura hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT bolttoki hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT tufmanamanda hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting AT kauffmannguerrerodiego hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting |